Veterinary Healthcare Market is estimated to be valued at USD 46,700 Mn in 2026 and is expected to reach USD 85,368 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033.
| Report Coverage |
Report Details |
| Base Year: |
2025 |
Market Size in 2026: |
USD 46,700 Mn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: |
9.00% |
2033 Value Projection: |
USD 85,368 Mn |
Veterinary healthcare focuses on effective animal health management by diagnosing and treating diseases. It is a medical specialty concerned with the prevention, diagnosis, control, and treatment of diseases affecting the health of domestic and wild animals, as well as to prevent transmission of veterinary diseases (zoonotic and chronic) worldwide. Early detection is key when it comes to treating health problems in animals.
Market Dynamics
Increase in incidence/prevalence of zoonosis diseases, increase in focus on veterinary healthcare, favorable initiatives by governments and animal welfare associations, increase in awareness about veterinary healthcare, rise in adoption of pets, and introduction of novel products are major factors expected to drive growth of the global veterinary healthcare market.
For instance, in September 2019, Abu Dhabi Agriculture and Food Safety Authority (ADAFSA) launched the 11th annual vaccination campaign for 2019-2020 against diseases affecting animals in the Emirate of Abu Dhabi. The campaign comes as part of ADAFSA's great support for livestock breeders in the emirate, to promote the best practices related to animal farming.
Moreover, in May 2020, Felix Pharmaceuticals Pvt. Ltd. announced that the U.S. Food and Drug Administration (FDA) approved its 'Enrofloxacin Flavored Tablets', for the treatment of diseases associated with bacteria.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global veterinary healthcare market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Zoetis Inc., Virbac SA, Vetoquinol SA, Phibro Animal Health, Merck & Co. Inc., IDEXX Laboratories, Ceva SantE Animale, BioMerieux SA, Elanco Animal Health Incorporated, and Boehringer Ingelheim International GmbH, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global veterinary healthcare market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary healthcare market.
Market Segmentation
- By Product (Revenue, USD Mn, 2021 - 2033)
- Therapeutics
- Diagnostics
- By Animal Type (Revenue, USD Mn, 2021 - 2033)
- Dogs and Cats
- Horses
- Ruminants
- Swine
- Poultry
- Other Animals
- By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Zoetis Inc.
- Virbac SA
- Vetoquinol SA
- Phibro Animal Health
- Merck & Co. Inc.
- IDEXX Laboratories
- Ceva SantE Animale
- BioMerieux SA
- Elanco Animal Health Incorporated
- Boehringer Ingelheim International GmbH